Literature DB >> 26026400

Improving health worker performance: The patient-perspective from a PBF program in Rwanda.

Laurence Lannes1.   

Abstract

The effect of performance-based financing (PBF) on patients' perception of primary health care services in developing countries in not well documented. Data from a randomized impact evaluation in Rwanda conducted between 2006 and 2008 in 157 primary level facilities is used to explore patients' satisfaction with clinical and non-clinical services and quantify the contribution of individual and facility characteristics to satisfaction including PBF. Improvements in productivity, availability and competences of the health workforce following the implementation of PBF have a positive effect on patients' satisfaction with clinical services even if patients' satisfaction is not tied to a reward. The positive effect of PBF on non-clinical dimensions of satisfaction also suggests that PBF incentivizes providers to raise patients' satisfaction with non-clinical services if it is associated with future financial gains. It is recommended that low and middle income countries build on the experience from high income countries to better listen to patients' voice in general and include an assessment of patients' satisfaction in incentive mechanisms as a way to increase the benefits of the strategy.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Health workforce performance; Incentives; Low and middle income countries; Patients' satisfaction; Rwanda

Mesh:

Year:  2015        PMID: 26026400     DOI: 10.1016/j.socscimed.2015.05.033

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  7 in total

1.  Paying for performance to improve the delivery of health interventions in low- and middle-income countries.

Authors:  Karin Diaconu; Jennifer Falconer; Adrian Verbel; Atle Fretheim; Sophie Witter
Journal:  Cochrane Database Syst Rev       Date:  2021-05-05

Review 2.  Primary health Centres' performance assessment measures in developing countries: review of the empirical literature.

Authors:  R Bangalore Sathyananda; A de Rijk; U Manjunath; A Krumeich; C P van Schayck
Journal:  BMC Health Serv Res       Date:  2018-08-09       Impact factor: 2.655

3.  What Happens When Donors Pull Out? Examining Differences in Motivation Between Health Workers Who Recently Had Performance-Based Financing (PBF) Withdrawn With Workers Who Never Received PBF in the Democratic Republic of Congo.

Authors:  Rishma Maini; Julia Lohmann; David R Hotchkiss; Sandra Mounier-Jack; Josephine Borghi
Journal:  Int J Health Policy Manag       Date:  2019-11-01

4.  Reducing time to differentiated service delivery for newly diagnosed people living with HIV in Kigali, Rwanda: study protocol for a pilot, unblinded, randomised controlled study.

Authors:  Jonathan Ross; Gad Murenzi; Sarah Hill; Eric Remera; Charles Ingabire; Francine Umwiza; Athanase Munyaneza; Benjamin Muhoza; Dominique Savio Habimana; Placidie Mugwaneza; Chenshu Zhang; Marcel Yotebieng; Kathryn Anastos
Journal:  BMJ Open       Date:  2021-04-24       Impact factor: 2.692

5.  Combining Theory-Driven Evaluation and Causal Loop Diagramming for Opening the 'Black Box' of an Intervention in the Health Sector: A Case of Performance-Based Financing in Western Uganda.

Authors:  Dimitri Renmans; Nathalie Holvoet; Bart Criel
Journal:  Int J Environ Res Public Health       Date:  2017-09-03       Impact factor: 3.390

6.  Intended and unintended effects: community perspectives on a performance-based financing programme in Malawi.

Authors:  Chisomo Petross; Shannon McMahon; Julia Lohmann; Rachel P Chase; Adamson S Muula; Manuela De Allegri
Journal:  BMJ Glob Health       Date:  2020-04-01

7.  How are pay-for-performance schemes in healthcare designed in low- and middle-income countries? Typology and systematic literature review.

Authors:  Roxanne J Kovacs; Timothy Powell-Jackson; Søren R Kristensen; Neha Singh; Josephine Borghi
Journal:  BMC Health Serv Res       Date:  2020-04-07       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.